The journey towards lung protective respiratory support in preterm neonates

Neonatology

Volumn 104, Issue 4, 2013, Pages 265-274

  Berger, Thomas M ^a   Fontana, Matteo ^a   Stocker, Martin ^a  

^a CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Antenatal corticosteroids; Atelectrauma; Bronchopulmonary dysplasia; Continuous positive airway pressure; Conventional mechanical ventilation; High frequency oscillatory ventilation; Lung protective strategies; Noninvasive respiratory support; Oxygen toxicity; Surfactant; Volutrauma

Indexed keywords

CORTICOSTEROID; LUNG SURFACTANT; NITRIC OXIDE; OXYGEN;

ARTERIAL OXYGEN SATURATION; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; CORTICOSTEROID THERAPY; FETUS LUNG MATURATION; HIGH FREQUENCY VENTILATION; HUMAN; HYALINE MEMBRANE DISEASE; INTERMITTENT POSITIVE PRESSURE VENTILATION; LUNG; LUNG DYSPLASIA; LUNG VENTILATION; MEDICAL TECHNOLOGY; NASOTRACHEAL INTUBATION; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONINVASIVE VENTILATION; OBSERVATIONAL STUDY; OXYGEN TOXICITY; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; REVIEW; RISK FACTOR; TIDAL VOLUME; VENTILATOR INDUCED LUNG INJURY;

ADRENAL CORTEX HORMONES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HIGH-FREQUENCY VENTILATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RESPIRATORY THERAPY;

EID: 84885061156     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000354419     Document Type: Review

References (73)

1. Campbell K: Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach. Med J Aust 1951; 2: 48-50.
2. Avery ME: Recent increase in mortality from hyaline membrane disease. J Pediatr 1960; 57: 553-559.
3. Avery ME, Mead J: Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child 1959; 97: 517-523.
4. Peterson HG Jr, Pendleton M: Contrasting roentgenographic pulmonary patterns of the hyaline membrane and fetal aspiration syndromes. Am J Roentgenol Radium Ther Nucl Med 1955; 74: 800-817.
5. Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T: Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980; 1: 55-59.
6. Northway WH Jr, Rosan RC, Porter DY: Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357-368.
7. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK: Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med 1971; 284: 1333-1340.
8. Liggins GC: Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969; 45: 515-523.
9. Liggins GC, Howie RN: A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515-525.
10. Roberts D, Dalziel S: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 3:CD004454.
11. Soll RF, Blanco F: Early versus delayed neonatal administration of a synthetic surfactant - the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency) - the role of surfactant. Lancet 1992; 340: 1363-1369.
12. Soll RF, Blanco F: Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2001; 2:CD000144.
13. Northway WH Jr: Bronchopulmonary dysplasia: twenty-five years later. Pediatrics 1992; 89: 969-973.
14. Donn SM: Neonatal ventilators: how do they differ? J Perinatol 2009; 29:S73-S78.
15. Greenough A, Dimitriou G, Prendergast M, Milner AD: Synchronized mechanical ventilation for respiratory support in newborn infants. Cochrane Database Syst Rev 2008; 1:CD000456.
16. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, et al: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338: 347-354.
17. ARDS Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308.
18. Wheeler KI, Klingenberg C, Morley CJ, Davis PG: Volume-targeted versus pressure-limited ventilation for preterm infants: a systematic review and meta-analysis. Neonatology 2011; 100: 219-227.
19. Van Kaam A: Lung-protective ventilation in neonatology. Neonatology 2011; 99: 338-341.
20. Gerstmann DR, deLemos RA, Coalson JJ, Clark RH, Wiswell TE, Winter DC, et al: Influence of ventilatory technique on pulmonary baroinjury in baboons with hyaline membrane disease. Pediatr Pulmonol 1988; 5: 82-91.
21. Carney D, DiRocco J, Nieman G: Dynamic alveolar mechanics and ventilator-induced lung injury. Crit Care Med 2005; 3:S122-S128.
22. The HIFI Study Group: High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med 1989; 320: 88-93.
23. Henderson-Smart DJ, De Paoli AG, Clark RH, Bhuta T: High frequency oscillatory ventilation versus conventional ventilation for infants with severe pulmonary dysfunction born at or near term. Cochrane Database Syst Rev 2009; 3:CD002974.
24. Cools F, Askie LM, Offringa M, Asselin JM, Calvert SA, Courtney SE, et al: Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients' data. Lancet 2010; 375: 2082-2091.
25. Soll RF: Elective High-Frequency Oscillatory Ventilation versus Conventional Ventilation for Acute Pulmonary Dysfunction in Preterm Infants. Neonatology 2012; 103: 7-9.
26. Bryan AC, Froese AB: Reflections on the HIFI trial. Pediatrics 1991; 87: 565-567.
27. Stevenson DK, Wright LL, Lemons JA, Oh W, Korones SB, Papile LA, et al: Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol 1998; 179: 1632-1639.
28. Husain AN, Siddiqui NH, Stocker JT: Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29: 710-717.
29. Jobe AJ: The new BPD: an arrest of lung development. Pediatr Res 1999; 46: 641-643.
30. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, et al: Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987; 79: 26-30.
31. Dunn MS, Kaempf J, de Klerk A, de Klerk R, Reilly M, Howard D, et al: Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics 2011; 128:e1069-e1076.
32. Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, et al: Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010; 362: 1970-1979.
33. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB: Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358: 700-708.
34. Rojas-Reyes MX, Morley CJ, Soll R: Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012; 3:CD000510.
35. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, et al: Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994; 331: 1051-1055.
36. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF: Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants
37. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, et al: Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol 2005; 25: 703-708.
38. Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, et al: Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009; 123: 137-142.
39. Tooley J, Dyke M: Randomized study of nasal continuous positive airway pressure in the preterm infant with respiratory distress syndrome. Acta Paediatr 2003; 92: 1170-1174.
40. Pfister RH, Soll RF: Initial respiratory support of preterm infants: the role of CPAP, the INSURE method, and noninvasive ventilation. Clin Perinatol 2012; 39: 459-481.
41. Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, et al: Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010; 125:e1402-e1409.
42. Kattwinkel J, Robinson M, Bloom BT, Delmore P, Ferguson JE: Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol 2004; 24: 360-365.
43. Trevisanuto D, Grazzina N, Ferrarese P, Micaglio M, Verghese C, Zanardo V: Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate 2005; 87: 217-220.
44. Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG: Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed 2011; 96:F243-F248.
45. Kribs A, Pillekamp F, Hunseler C, Vierzig A, Roth B: Early administration of surfactant in spontaneous breathing with nCPAP: Feasibility and outcome in extremely premature infants (postmenstrual age
46. Gopel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, et al: Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011; 378: 1627-1634.
47. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U: Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics 2013; 131:e502-e509.
48. Finer NN, Barrington KJ: Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2006; 4:CD000399.
49. Sosenko IR, Bancalari E: NO for preterm infants at risk of bronchopulmonary dysplasia. Lancet 2010; 376: 308-310.
50. Barrington KJ, Finer N: Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2010; 12:CD000509.
51. Donohue PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD, et al: Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 2011; 127:e414-e422.
52. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al: Caffeine therapy for apnea of prematurity. N Engl J Med 2006; 354: 2112-2121.
53. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al: Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007; 357: 1893-1902.
54. Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, et al: Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012; 307: 275-282.
55. Bjorklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O, et al: Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 1997; 42: 348-355.
56. De Jaegere A, van Veenendaal MB, Michiels A, van Kaam AH: Lung recruitment using oxygenation during open lung high-frequency ventilation in preterm infants. Am J Respir Crit Care Med 2006; 174: 639-645.
57. Sturtz WJ, Touch SM, Locke RG, Greenspan JS, Shaffer TH: Assessment of neonatal ventilation during high-frequency oscillatory ventilation. Pediatr Crit Care Med 2008; 9: 101-104.
58. Pillow JJ: High-frequency oscillatory ventilation: mechanisms of gas exchange and lung mechanics. Crit Care Med 2005; 33:S135-S141.
59. Venegas JG, Fredberg JJ: Understanding the pressure cost of ventilation: why does highfrequency ventilation work? Crit Care Med 1994; 22:S49-S57.
60. Ryu J, Haddad G, Carlo WA: Clinical effectiveness and safety of permissive hypercapnia. Clin Perinatol 2012; 39: 603-612.
61. Saugstad OD, Aune D: In search of the optimal oxygen saturation for extremely low birth weight infants: a systematic review and metaanalysis. Neonatology 2011; 100: 1-8.
62. Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, Laptook AR, et al: Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010; 362: 1959-1969.
63. Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y, et al: Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA 2013; 309: 2111-2120.
64. Stenson BJ, Tarnow-Mordi WO, Darlow BA, Simes J, Juszczak E, Askie L, et al: Oxygen saturation and outcomes in preterm infants. N Engl J Med 2013; 368: 2094-2104.
65. Vaucher YE, Peralta-Carcelen M, Finer NN, Carlo WA, Gantz MG, Walsh MC, et al: Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med 2012; 367: 2495-2504.
66. Bancalari E, Claure N: Oxygenation targets and outcomes in premature infants. JAMA 2013; 309: 2161-2162.
67. Polin RA, Bateman D: Oxygen-saturation targets in preterm infants. N Engl J Med 2013; 368: 2141-2142.
68. Bhandari V, Gavino RG, Nedrelow JH, Pallela P, Salvador A, Ehrenkranz RA, et al: A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS. J Perinatol 2007; 27: 697-703.
69. Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D: Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. J Pediatr 2007; 150: 521-526.
70. Owen LS, Morley CJ, Dawson JA, Davis PG: Effects of non-synchronised nasal intermittent positive pressure ventilation on spontaneous breathing in preterm infants. Arch Dis Child Fetal Neonatal Ed 2011; 96:F422-F428.
71. Beck J, Reilly M, Grasselli G, Mirabella L, Slutsky AS, Dunn MS, et al: Patient-ventilator interaction during neurally adjusted ventilatory assist in low birth weight infants. Pediatr Res 2009; 65: 663-668.
72. Kamath BD, Macguire ER, McClure EM, Goldenberg RL, Jobe AH: Neonatal mortality from respiratory distress syndrome: lessons for low-resource countries. Pediatrics 2011; 127: 1139-1146.
73. Berger TM. Neonatal respiratory care: not how, but where and when. Lancet Resp Med 2013; 1: 280-282.